Bio-Techne Corporation (TECH) 의 후행 P/E는 104.5, 선행 P/E 29.6. 후행 이익수익률은 0.96%, 선행 이익수익률 3.38%. PEG 0.09 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $12.29.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 64/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 40.1 | -9.77 | 4.77 | 8.40 | 1.14% |
| 2017 | 56.7 | -2.21 | 4.61 | 7.79 | 1.08% |
| 2018 | 44.2 | 0.72 | 5.14 | 8.62 | 0.87% |
| 2019 | 82.3 | -3.46 | 6.78 | 11.07 | 0.61% |
| 2020 | 44.0 | 0.33 | 7.30 | 13.66 | 0.48% |
| 2021 | 124.3 | -3.16 | 11.16 | 18.74 | 0.28% |
| 2022 | 50.0 | 0.55 | 7.99 | 12.30 | 0.37% |
| 2023 | 45.0 | 9.73 | 6.52 | 11.29 | 0.39% |
| 2024 | 67.2 | -1.64 | 5.46 | 9.74 | 0.45% |
| 2025 | 110.4 | -1.97 | 4.22 | 6.64 | 0.62% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $0.70 | $499.02M | $104.48M | 20.9% |
| 2017 | $0.52 | $563M | $77.29M | 13.7% |
| 2018 | $0.82 | $642.99M | $125.35M | 19.5% |
| 2019 | $0.62 | $714.01M | $96.07M | 13.5% |
| 2020 | $1.45 | $738.69M | $229.3M | 31% |
| 2021 | $0.87 | $931.03M | $140.41M | 15.1% |
| 2022 | $1.66 | $1.11B | $272.05M | 24.6% |
| 2023 | $1.76 | $1.14B | $285.26M | 25.1% |
| 2024 | $1.05 | $1.16B | $168.11M | 14.5% |
| 2025 | $0.46 | $1.22B | $73.4M | 6% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $1.98 | $1.94 – $2.05 | $1.22B | $1.21B – $1.23B | 8 |
| 2027 | $2.19 | $2.04 – $2.30 | $1.3B | $1.28B – $1.33B | 8 |
| 2028 | $2.55 | $2.25 – $2.79 | $1.44B | $1.44B – $1.44B | 3 |
| 2029 | $3.03 | $2.98 – $3.08 | $1.53B | $1.51B – $1.55B | 1 |
| 2030 | $3.15 | $3.10 – $3.21 | $1.71B | $1.69B – $1.73B | 1 |
